MedTrace Logo

Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men

NCT00740194 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-08-30

No results posted yet for this study

Summary

Aromatase inhibition versus estradiol during 1 week

Conditions

  • Healthy

Interventions

DRUG

Aromatase inhibition

Letrozole

DRUG

Estradiol

Dermestril

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Johannes Ruige, MD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-12-31
Completion
2010-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00740194 on ClinicalTrials.gov